1803, 2024

Design, Synthesis, and Pharmacological Characterization of a Potent Soluble Epoxide Hydrolase Inhibitor for the Treatment of Acute Pancreatitis

Marzo 18th, 2024|

Abstract Acute pancreatitis (AP) is a potentially life-threatening illness characterized by an exacerbated inflammatory response with limited options for pharmacological treatment. Here, we describe the rational development of a library of soluble epoxide hydrolase (sEH) inhibitors for the treatment of [...]

1803, 2024

Novel pyrrole based CB2 agonists: New insights on CB2 receptor role in regulating neurotransmitters’ tone

Marzo 18th, 2024|

Abstract The cannabinoid system is one of the most investigated neuromodulatory systems because of its involvement in multiple pathologies such as cancer, inflammation, and psychiatric diseases. Recently, the CB2 receptor has gained increased attention considering its crucial role in modulating [...]

3001, 2024

Zonulin as a Biomarker for the Development of Celiac Disease

Gennaio 30th, 2024|

Abstract Objectives: Increased intestinal permeability seems to be a key factor in the pathogenesis of autoimmune diseases, including celiac disease (CeD). However, it is unknown whether increased permeability precedes CeD onset. This study's objective was to determine whether intestinal permeability is [...]

1601, 2024

Outcomes in people with eating disorders: a transdiagnostic and disorder‐specific systematic review, meta‐analysis and multivariable meta‐regression analysis

Gennaio 16th, 2024|

Abstract Eating disorders (EDs) are known to be associated with high mortality and often chronic and severe course, but a recent comprehensive systematic review of their outcomes is currently missing. In the present systematic review and meta‐analysis, we examined cohort [...]

1812, 2023

Zonulin as a Biomarker for the Development of Celiac Disease

Dicembre 18th, 2023|

Abstract Objectives: Increased intestinal permeability seems to be a key factor in the pathogenesis of autoimmune diseases, including celiac disease (CeD). However, it is unknown whether increased permeability precedes CeD onset. This study's objective was to determine whether intestinal permeability is [...]

2411, 2023

A narrative review of digital biomarkers in the management of major depressive disorder and treatment-resistant forms

Novembre 24th, 2023|

Introduction: Depression is the leading cause of worldwide disability, until now only 3% of patients with major depressive disorder (MDD) experiences full recovery or remission. Different studies have tried to better understand MDD pathophysiology and its resistant forms (TRD), focusing on [...]

1910, 2023

Editorial: Psychometrics in psychiatry 2022: psychological therapy and psychosomatics

Ottobre 19th, 2023|

Editorial on the Research Topic Psychometrics in psychiatry 2022: psychological therapy and psychosomatics The importance of evidence-based assessment and measurement in mental healthcare has become increasingly recognized in recent decades. However, psychiatry has long grappled with challenges in quantifying subjective [...]

3008, 2023

Balancing risks and benefits of cannabis use: umbrella review of meta-analyses of randomised controlled trials and observational studies

Agosto 30th, 2023|

Abstract Objective To systematically assess credibility and certainty of associations between cannabis, cannabinoids, and cannabis based medicines and human health, from observational studies and randomised controlled trials (RCTs). Design Umbrella review. Data sources PubMed, PsychInfo, Embase, up to 9 February [...]

208, 2023

Incidence, prevalence, and global burden of schizophrenia – data, with critical appraisal, from the Global Burden of Disease (GBD) 2019

Agosto 2nd, 2023|

Abstract Schizophrenia substantially contributes to the burden of mental disorders. Schizophrenia’s burden and epidemiological estimates in some countries have been published, but updated estimates of prevalence, incidence, and schizophrenia-related disability at the global level are lacking. Here, we present the [...]

1001, 2023

In Silico Identification and In Vitro Evaluation of New ABCG2 Transporter Inhibitors as Potential Anticancer Agents

Gennaio 10th, 2023|

Abstract Different molecular mechanisms contribute to the development of multidrug resistance in cancer, including increased drug efflux, enhanced cellular repair mechanisms and alterations of drug metabolism or drug targets. ABCG2 is a member of the ATP-binding cassette superfamily transporters that [...]

2112, 2022

Editorial: Novel Strategies in Drug Development Against Multifactorial Diseases

Dicembre 21st, 2022|

Editorial on the Research Topic Novel Strategies in Drug Development Against Multifactorial Diseases The complexity of multifactorial diseases, such as inflammation, cancer, neurodegenerative disorders, infectious pathologies represents a key obstacle in the success of therapeutic intervention. The occurrence of acquired [...]